Analysis of Infectious Disease Testing Instrumentation in Global Industry : Market Development and Overview 2016-2020
Researchmoz added Most up-to-date research on "Infectious Disease Testing Instrumentation Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its huge collection of research reports.
Infectious disease is currently the largest and well established segment of molecular diagnostics market. Testing of human papilloma virus which is a major cause of cervical cancer is expected to propel the infectious diseases testing market as the test is still in the emerging stage. Rise in incidences of hospital acquired infections, longer stay in the hospital that is associated with increased mortality and morbidity coupled with reduced cost has spurred the demand the rapid molecular diagnostics test for hospital acquired infections. Molecular technology continues to evolve with the goal of providing more accurate means of disease detection and monitoring. Timely infectious disease testing offers numerous advantages, including rapid test results assisting in detection of outbreaks as well as newly emerging strains. Molecular diagnostics offer specificity, sensitivity, identification of resistant organisms, and quantifiable correlation to disease severity. All these factors eventually contribute to well-timed therapeutic clinical decisions and early infection control.
Multiplex methods involve simultaneous detection of multiple infectious agents in a single clinical sample. In addition, these methods are able to identify organisms that may be difficult to isolate or have not been cultured by traditional methods. High prevalence of infectious diseases such as Herpes Simplex Virus (HSV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), hepatitis C virus (HCV), measles, tuberculosis, dengue, cholera, Chagas, and malaria is increasing across the globe, especially in developing countries. Advancements in the in vitro diagnostics have enabled prototype shift from laboratory testing to point of care testing and is thus helping in development of infectious diseases testing instrumentation market.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=235027
The global infectious disease testing instrumentation can be segmented on the basis of test type, and geography. Tests include all the in vitro diagnostic tests such as immunochemistry testing, microbiology testing, molecular diagnostics, companion diagnostics and multiplexed diagnostic testing. Advantages of molecular diagnostics have resulted in early detection with high specificity as well as mitigation of infectious diseases. The global infectious disease testing instrumentation market is also expected to be driven by development of various new assays for diagnosis and treatment of infectious diseases. Other factors responsible for propelling the growth of infectious disease testing instrumentation market include increase in geriatric population pool and rising incidences of chronic infectious diseases.
Geographically, the global market for infectious disease testing instrumentation is segmented into four major regions, namely, North America, Europe, Asia Pacific and Rest of the World. North America and Europe account for largest share globally, though high growth is expected to be witnessed in the emerging markets of Asia Pacific. This has been attributed to the rising demand for infectious diseases in vitro diagnostics, rapid population growth, and increasing investments in healthcare infrastructure in this region. Reduction in cost per sample analysis and labor costs, introduction of advanced technologies and improvements in automation has extended the infectious disease testing instrumentation use in numerous areas. Similarly, rise in elderly population, growing incidence of chronic infectious diseases and rise in cancer incidence are some the factors that have augmented the growth of infectious disease testing market.
Some of the key players contributing to the global infectious disease testing instrumentation market are Abbott Laboratories Ltd., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., bioMerieux, Inc., Becton, Dickinson & company, Siemens Healthcare, Thermo Fischer Scientific, Roche Diagnostics, and Qiagen N.V.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Infectious disease is currently the largest and well established segment of molecular diagnostics market. Testing of human papilloma virus which is a major cause of cervical cancer is expected to propel the infectious diseases testing market as the test is still in the emerging stage. Rise in incidences of hospital acquired infections, longer stay in the hospital that is associated with increased mortality and morbidity coupled with reduced cost has spurred the demand the rapid molecular diagnostics test for hospital acquired infections. Molecular technology continues to evolve with the goal of providing more accurate means of disease detection and monitoring. Timely infectious disease testing offers numerous advantages, including rapid test results assisting in detection of outbreaks as well as newly emerging strains. Molecular diagnostics offer specificity, sensitivity, identification of resistant organisms, and quantifiable correlation to disease severity. All these factors eventually contribute to well-timed therapeutic clinical decisions and early infection control.
Multiplex methods involve simultaneous detection of multiple infectious agents in a single clinical sample. In addition, these methods are able to identify organisms that may be difficult to isolate or have not been cultured by traditional methods. High prevalence of infectious diseases such as Herpes Simplex Virus (HSV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), hepatitis C virus (HCV), measles, tuberculosis, dengue, cholera, Chagas, and malaria is increasing across the globe, especially in developing countries. Advancements in the in vitro diagnostics have enabled prototype shift from laboratory testing to point of care testing and is thus helping in development of infectious diseases testing instrumentation market.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=235027
The global infectious disease testing instrumentation can be segmented on the basis of test type, and geography. Tests include all the in vitro diagnostic tests such as immunochemistry testing, microbiology testing, molecular diagnostics, companion diagnostics and multiplexed diagnostic testing. Advantages of molecular diagnostics have resulted in early detection with high specificity as well as mitigation of infectious diseases. The global infectious disease testing instrumentation market is also expected to be driven by development of various new assays for diagnosis and treatment of infectious diseases. Other factors responsible for propelling the growth of infectious disease testing instrumentation market include increase in geriatric population pool and rising incidences of chronic infectious diseases.
Geographically, the global market for infectious disease testing instrumentation is segmented into four major regions, namely, North America, Europe, Asia Pacific and Rest of the World. North America and Europe account for largest share globally, though high growth is expected to be witnessed in the emerging markets of Asia Pacific. This has been attributed to the rising demand for infectious diseases in vitro diagnostics, rapid population growth, and increasing investments in healthcare infrastructure in this region. Reduction in cost per sample analysis and labor costs, introduction of advanced technologies and improvements in automation has extended the infectious disease testing instrumentation use in numerous areas. Similarly, rise in elderly population, growing incidence of chronic infectious diseases and rise in cancer incidence are some the factors that have augmented the growth of infectious disease testing market.
Some of the key players contributing to the global infectious disease testing instrumentation market are Abbott Laboratories Ltd., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., bioMerieux, Inc., Becton, Dickinson & company, Siemens Healthcare, Thermo Fischer Scientific, Roche Diagnostics, and Qiagen N.V.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Comments
Post a Comment